Trillium Therapeutics Inc. announced the following key additions to its leadership team:
- Blythe Thomson, MD, Executive Medical Director
- Jane E. Cole, RN, Senior Director, Clinical Operations
- Brian E. Jahns, PharmD, Senior Vice President, Commercial and Business Development
“These additions to our management team further bolsters our planned pipeline development activities. Our new team members bring diverse and deep drug development expertise, and will have a major impact on the advancement of our TTI-621 program and corporate growth. Under Dr. Sievers’ guidance, our TTI-621 program has been well positioned for advancement in 2018. We look forward to continued benefit from Dr. Sievers’ expertise in his new role.”